Fresenius Group Overview

Outlook

Group Outlook 2019

In 2019, we expect to increase Group sales1 by 3% to 6% in constant currency. We project Group net income2,3 to increase by ~ 0% in constant currency.

  Targets 2019 Fiscal year 20184
Fresenius Group
Sales growth (in constant currency) 3% – 6%5 € 33,009 million

Net income2 growth
(in constant currency)

~0%6 € 1,872 million
Fresenius Medical Care

Sales growth (in constant currency)

3% – 7%6 € 16,026 million
Net income7 growth (in constant currency) -2% – +2%6 € 1,341 million
Fresenius Kabi
Sales growth (organic) 3% – 6%6 € 6,544 million
EBIT growth (in constant currency) 3% – 6%6 € 1,139 million
Fresenius Helios
Sales growth (organic) 2% – 5%6 € 8,993 million
EBIT growth -5% – -2%6 € 1,052 million
Fresenius Vamed
Sales growth (organic) ~10%6 € 1,688 million
EBIT growth 15% – 20%6 € 110 million

 

  • 1 Base 2018: €33,009 million; 2018 adjusted for divestitures of Care Coordination activities at FMC (H1 / 18); 2019 adjusted for IFRS 16 effects, excluding effects from pending acquisition of NxStage by FMC
  • 2 Net income attributable to shareholders of Fresenius SE & Co. KGaA
  • 3 Base 2018: € 1,872 million; 2018 before special items and adjusted for divestitures of Care Coordination activities at FMC (H1 /18); 2019 before special items (before transaction-related expenses, expenses associated with the cost optimization program at FMC, revaluations of biosimilars contingent liabilities), adjusted for IFRS 16 effects, excluding effects from pending acquisition of NxStage by FMC
  • 4 Before special items and after adjustments
  • 5 Adjusted for effects of IFRS 16, excluding effects from pending acquisition of NxStage by FMC
  • 6 Before special items (before transaction-related expenses, expenses associated with the cost optimization program at FMC, revaluations of biosimilars contingent liabilities), adjusted for IFRS 16 effects, excluding effects from pending acquisition of NxStage by FMC
  • 7 Net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA
  •  
  • As of December 31, 2018